One last footnote on unraveling the mystery behind
Post# of 148126
https://academic.oup.com/cid/article/75/7/123...ogin=false
It should be emphasized that the study results were NOT expected. That should really intrigue the curious but It goes to the heart of Leronlimab’s mechanism of action having to do with immune modulation. Leronlimab was found to RAISE CCR5 expression on patients who at the core had some immune suppression.
I am in the middle of a very interesting podcast interview between Kate Bowler and Maggie Jackson regarding the latter’s book “The Wisdom of Uncertainty.” We humans don’t like uncertainty, it can provoke anxiety and fear…that was the pandemic in a nutshell as the medical community scrambled to find something, anything that worked. The plethora of symptoms surrounding long covid has the NIH and others scratching their heads trying to make sense of it. If you lean into the uncertainty with curiosity and sit with it, try to understand it and work through it, that is where the green buds of growth occur in human experience. Cytodyn offered the clinical community what I believe is a major insight with the long covid study. There are numerous participants in that study that are unequivocal in that it started to give them their life back.
Leronlimab was put on the shelf for a time; the NIH and everyone else uncertain what to trial or why should take another look at the gift Cytodyn offered up with that study.